Citadel Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $569K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $266K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $510K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $418K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $626K | Buy |
|
|||||
|
2022
Q1 | $265K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $231K | Sell |
|
|||||
|
2021
Q2 | $304K | Sell |
|
|||||
|
2021
Q1 | $583K | Buy |
|
|||||
|
2020
Q4 | $332K | Sell |
|
|||||
|
2020
Q3 | $1.78M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.77M | Sell |
|
|||||
|
2019
Q4 | $2.45M | Sell |
|
|||||
|
2019
Q3 | $2.38M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $1.89M | Buy |
|
|||||
|
2018
Q4 | $233K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $730K | Buy |
|
|||||
|
2018
Q1 | $222K | Sell |
|
|||||
|
2017
Q4 | $400K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1.38M | Buy |
|
|||||
|
2016
Q4 | $1.2M | Sell |
|
|||||
|
2016
Q3 | $2.13M | Buy |
|
|||||
|
2016
Q2 | $378K | Sell |
|
|||||
|
2016
Q1 | $804K | Sell |
|
|||||
|
2015
Q4 | $1.82M | Buy |
|
|||||
|
2015
Q3 | $1.23M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1.64M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $876K | Buy |
|